Come up with a name for your new list and we'll add to it:
Bluebird Bio raised a round of funding on November 23, 2010. Investors include
Qualifying Therapeutic Discovery Project.
Bluebird Bio, formerly Genetix Pharmaceuticals, is developing gene therapies for severe genetic disorders. At the heart of bluebird bio's product creation efforts is its broadly applicable gene therap…